LU91769I2 - Ditartrate de Vinflunine. - Google Patents

Ditartrate de Vinflunine.

Info

Publication number
LU91769I2
LU91769I2 LU91769C LU91769C LU91769I2 LU 91769 I2 LU91769 I2 LU 91769I2 LU 91769 C LU91769 C LU 91769C LU 91769 C LU91769 C LU 91769C LU 91769 I2 LU91769 I2 LU 91769I2
Authority
LU
Luxembourg
Prior art keywords
vinflunine
formula
preparation
ditartrate
sbf5
Prior art date
Application number
LU91769C
Other languages
English (en)
French (fr)
Original Assignee
Pierre Fabre Medicament Production
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament Production filed Critical Pierre Fabre Medicament Production
Publication of LU91769I2 publication Critical patent/LU91769I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
LU91769C 1997-04-10 2010-12-22 Ditartrate de Vinflunine. LU91769I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
EP98920607A EP0975640B1 (fr) 1997-04-10 1998-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
EP20030017052 EP1357125A3 (fr) 1997-04-10 1998-04-10 Procédé de préparation de dérivés halogénés d'alcaloides de vinca

Publications (1)

Publication Number Publication Date
LU91769I2 true LU91769I2 (fr) 2011-02-22

Family

ID=9505731

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91769C LU91769I2 (fr) 1997-04-10 2010-12-22 Ditartrate de Vinflunine.

Country Status (15)

Country Link
US (1) US6127377A (OSRAM)
EP (3) EP1764368B1 (OSRAM)
JP (3) JP4401440B2 (OSRAM)
AT (2) ATE473987T1 (OSRAM)
AU (1) AU737549C (OSRAM)
BR (2) BR9807944B1 (OSRAM)
CA (3) CA2286560C (OSRAM)
CY (2) CY1111476T1 (OSRAM)
DE (3) DE69841766D1 (OSRAM)
DK (2) DK1764368T3 (OSRAM)
ES (2) ES2347878T3 (OSRAM)
FR (2) FR2761990B1 (OSRAM)
LU (1) LU91769I2 (OSRAM)
PT (2) PT975640E (OSRAM)
WO (1) WO1998045301A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) * 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
JP5448299B2 (ja) * 2003-12-04 2014-03-19 アルバニー モレキュラー リサーチ, インコーポレイテッド ビンカ誘導体
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Birドメイン結合化合物
FR2894966B1 (fr) 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
SG10201407457UA (en) 2006-05-16 2014-12-30 Pharmascience Inc Iap bir domain binding compounds
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) * 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
MX340870B (es) 2010-02-12 2016-07-27 Pharmascience Inc Compuestos de unión del dominio de repetición de inhibidores de proteínas de apoptosis de baculovirus.
EP2539339B1 (en) 2010-02-22 2014-05-14 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
WO2026064527A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload
WO2026064520A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
JP2001518892A (ja) 2001-10-16
ES2222588T3 (es) 2005-02-01
CA2286560C (fr) 2009-09-08
WO1998045301A1 (fr) 1998-10-15
EP0975640B1 (fr) 2004-06-30
FR10C0045I2 (fr) 2011-04-29
JP4307292B2 (ja) 2009-08-05
CA2455416C (fr) 2010-11-02
ES2347878T3 (es) 2010-11-22
BR9807944A (pt) 2000-03-08
AU737549C (en) 2002-03-28
FR10C0045I1 (OSRAM) 2010-10-29
DK0975640T3 (da) 2004-11-01
CY2010019I1 (el) 2012-01-25
EP1357125A2 (fr) 2003-10-29
ATE473987T1 (de) 2010-07-15
DE122010000054I1 (de) 2011-05-05
ATE270297T1 (de) 2004-07-15
US6127377A (en) 2000-10-03
FR2761990A1 (fr) 1998-10-16
BR9807944B1 (pt) 2011-02-08
DK1764368T3 (da) 2010-10-18
CA2286560A1 (fr) 1998-10-15
CA2665949A1 (fr) 1998-10-15
EP0975640A1 (fr) 2000-02-02
EP1357125A3 (fr) 2003-11-26
DE69824840T2 (de) 2005-07-21
JP2009167196A (ja) 2009-07-30
JP2004277418A (ja) 2004-10-07
CA2455416A1 (fr) 1998-10-15
PT975640E (pt) 2004-11-30
CY1111476T1 (el) 2012-01-25
EP1764368B1 (fr) 2010-07-14
PT1764368E (pt) 2010-09-16
JP4401440B2 (ja) 2010-01-20
CY2010019I2 (el) 2012-01-25
DE69824840D1 (de) 2004-08-05
CA2665949C (fr) 2013-06-11
EP1764368A1 (fr) 2007-03-21
AU737549B2 (en) 2001-08-23
FR2761990B1 (fr) 1999-06-25
AU7340898A (en) 1998-10-30
DE69841766D1 (de) 2010-08-26
BR9816177B1 (pt) 2010-08-24

Similar Documents

Publication Publication Date Title
FR10C0045I1 (OSRAM)
YU208687A (en) Process for obtaining analog of rebecamicine
SE7508332L (sv) Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel.
ES2173316T3 (es) Derivados de galantamina y proceso para su preparacion.
ES8308889A1 (es) Un procedimiento para la preparacion de nuevos derivados amonicos mono y bis-cuaternarios de 2 beta, 16 beta-diamino-5 alfa-androstanos.
HUT40090A (en) New process for production of derivatives of hh-1,2,4-triasole
ATE44742T1 (de) Verfahren zur herstellung von ergoline n-methyl- derivaten.
NO159926C (no) Fremgangsmaate for fremstilling av perfluoralkankarboksylsyrer.
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
ES8300696A1 (es) "procedimiento para preparar tiocarnitinas".
JPS51113890A (en) Method for preparing novel cephalosporins
JPS57192341A (en) Isoprenylamine derivative
JPS54148750A (en) Novel halogenoacetanilide derivative and its preparation
UA6324A1 (uk) Спосіб одержання похідних 6-фтор-1, дігідро-4-оксо-7-заміщений піперазінілхінолін-3-карбонової кислоти або їх фармацевтично прийнятних солей
JPS5775996A (en) Derivative of 4'''-aminoaclacinomycin a